Concepedia
Statistics
Publications
15
Citations
1.6K
H-Index
13
Active since
2010
Affiliations
Gilead Sciences (United States)(Current)
Texas Liver Institute
Inova Fairfax Hospital
Chinese University of Hong Kong
The University of Texas at San Antonio Health Science Center
Ryan S. Huss is an author at Gilead Sciences (United States) specializing in liver disease, medicine, and chronic liver disease.
Publications per year
2010–2023
Combination Therapies Including Cilofexor and Firsocostat for Bridging Fibrosis and Cirrhosis Attributable to NASH
Rohit Loomba, Mazen Noureddin, Kris V. Kowdley et al. · Hepatology · 2020 · 278 citations
Medicine, Pharmacology, Pharmacotherapy +17
Safety and efficacy of combination therapy with semaglutide, cilofexor and firsocostat in patients with non-alcoholic steatohepatitis: A randomised, open-label phase II trial
Naim Alkhouri, Robert Herring, Heidi Kabler et al. · Journal of Hepatology · 2022 · 209 citations
Medicine, Pharmacology, Pharmacotherapy +16
Enhanced diagnosis of advanced fibrosis and cirrhosis in individuals with NAFLD using FibroScan-based Agile scores
Arun J. Sanyal, Julie Foucquier, Zobair M. Younossi et al. · Journal of Hepatology · 2022 · 199 citations · Full text
Medicine, Internal Medicine, Pathology +14
A Machine Learning Approach Enables Quantitative Measurement of Liver Histology and Disease Monitoring in NASH
Amaro Taylor‐Weiner, Harsha Pokkalla, Ling Han et al. · Hepatology · 2021 · 195 citations · Full text
Medicine, Pathology, Hepatology +16
Cirrhosis regression is associated with improved clinical outcomes in patients with nonalcoholic steatohepatitis
Arun J. Sanyal, Quentin M. Anstee, Michael Trauner et al. · Hepatology · 2021 · 151 citations · Full text
Medicine, Internal Medicine, Pharmacotherapy +17
1–5 of 15